Status | Study |
NOT_YET_RECRUITING |
Study Name: Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease Condition: Rhabdomyosarcoma Date: 2023-08-27 Interventions: Low -risk Administer IV push over 1 minute (or infusion via minibag as per institutional standards) on Day 1 of Weeks 1,8, 15 (3) doses.The m |
Not yet recruiting |
Study Name: Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children Condition: Malignant Neoplasms of Mesothelial and Soft Tissue Rhabdomyosarcoma Date: 2017-04-06 Interventions: Procedure: Abdominal Surgery |
Recruiting |
Study Name: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma Condition: Rhabdomyosarcoma Rhabdomyosarcoma- Date: 2017-02-02 Interventions: Drug: Dasatinib Once daily on |
Recruiting |
Study Name: Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors Condition: Ewing Sarcoma Rhabdomyosarcoma Date: 2015-10-19 Interventions: Radiation: Stereotactic Body Radiotherapy (SBRT) |
Active, not recruiting |
Study Name: A Study Comparing Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping Condition: Rhabdomyosarcoma Melanoma Date: 2015-07-24 Interventions: Drug: Tc99m tilmanocept A sing |
Recruiting |
Study Name: Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy Condition: Rhabdomyosarcoma Date: 2013-05-30 Interventions: Drug: Vincristine |
Withdrawn |
Study Name: A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma Condition: Medulloblastoma, Childhood Rhabdomyosarcoma Date: 2012-09-28 Interventions: Drug: LY2940680 Capsule admini |
Completed |
Study Name: Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma Condition: Alveolar Childhood Rhabdomyosarcoma Embryonal Childhood Date: 2012-06-20 Interventions: Other: laboratory biomarker analysis Correlative studies |
Completed |
Study Name: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma Condition: Alveolar Childhood Rhabdomyosarcoma Embryonal Childhood Date: 2012-05-30 Interventions: Other: laboratory biomarker analysis Correlative studies |
Completed |
Study Name: Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma Condition: Sarcoma Date: 2012-04-24 Interventions: Genetic: mutation analysis Genetic: nuclei |